BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-07994525 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-07994525\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07426757-11282@assetmemo.bio
DTSTAMP:20261121T005446Z
DTSTART;VALUE=DATE:20290710
DTEND;VALUE=DATE:20290711
SUMMARY:PF-07994525: Phase 1 readout est. (NCT07426757)
DESCRIPTION:PF-07994525\, phase 1.\nStudy: An Open-Label Study to Evaluate 
 PF-07994525 in Participants With Advanced Cancers\nEstimated primary compl
 etion: 10 July 2029. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 pf-07994525#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT07426757
URL:https://assetmemo.bio/drug/pf-07994525#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
